Articles

The U.S. Supreme Court has upheld a Tennessee state statute that banned certain medical interventions for minors for purposes of attempting to change sexual identity or to address discomfort with sexual identity. In United States v. Skrmetti, by a 6-3 vote, the Court on June 18, 2025, determined that constitutional review of the state law did not require higher-level legal scrutiny and that the state law met the applicable legal standard for constitutionality.

Delegation Chair and Vice Chair, Jill Owens, MD and John Vasudevan, MD, led twenty-eight members of the Pennsylvania Delegation to the American Medical Association (AMA) at the Annual Meeting of the AMA House of Delegates (HOD or the House) in Chicago from June 6 – 11, 2025.

The Pennsylvania Department of Health (DOH) is forwarding the following advisory to health care providers, “Responding to Overdose and Withdrawal Involving Medetomidine” from the Philadelphia Department of Public Health (PDPH).

The Department of Human Services (Department) announces changes to the Medical Assistance (MA) Program Fee Schedule. These changes are effective for dates of service on and after June 16, 2025.

The Department of Human Services is announcing its intent to increase the funding for a class of disproportionate share hospital payments to qualifying hospitals for Fiscal Year 2024-2025.

The Secretary of Health of the Department of Health is publishing this notice of intent to issue a final notice to temporarily schedule any material, compound, mixture or preparation which contains any quantity of certain Nitazene substances, their salts, isomers and salts of isomers.

Introduced by Representative Lisa Borowski (D-Delaware), House Bill 1460 aims to strengthen oversight of major healthcare transactions involving private equity and large health systems.

The State Board of Osteopathic Medicine (board) has discovered the text of § 25.241(5.1) was inadvertently omitted when amendments to § 25.241 were published in the January 18, 2025, edition of the Pennsylvania Bulletin (55 Pa.B. 457).

The Preventative Health and Health Services Block Grant Advisory Committee will hold a public meeting on Tuesday, June 17, 2025 to present the Federal Fiscal Year 2025 Workplan and budget information.

On April 24, 2025, the Centers for Medicare & Medicaid Services approved the Commonwealth's application for an extension of its 1332 State Innovation Waiver under the Affordable Care Act (ACA) for an additional 5 years.

PAMED’s annual House of Delegates (HOD) meeting has long served as a platform for physicians to make their voices heard, shaping policies that influence the practice of medicine in Pennsylvania.

The Pharmaceutical Assistance Advisory Board will hold a meeting by means of Microsoft Teams on Monday, June 16, 2025, from 1 p.m. to 2:30 p.m.

The Patient Safety Authority (Authority) announces a meeting of the Authority's Board to be held virtually by means of the Authority's webinar platform Zoom on Tuesday, June 17, 2025, at 1 p.m. and is open to the general public.

The temporary scheduling of any material, compound, mixture or preparation which contains any quantity of certain Nitazene substances, their salts, isomers and salts of isomers will expire on June 3, 2025.

The Food and Drug Administration (FDA or the Agency) is hosting a public meeting on the reauthorization of the Generic Drug User Fee Amendments (GDUFA) for fiscal years (FYs) 2028 to 2032.

The Department of Health and Human Services (HHS or the Department) has rescinded four informal documents. This action will reduce the burdens on regulated parties and allow HHS to refocus on its core mission to Make America Healthy Again.

Recent updates from the Centers for Medicare & Medicaid Services.

The Board of Pharmacy (Board) is amending existing regulations to incorporate the mandatory reporting requirements under the CPSL into Chapter 27 (relating to State Board of Pharmacy), including the mandatory training requirements required by Act 31 of 2014.

To implement the President's Deregulatory Initiatives, including Department of Government Efficiency Deregulatory Agenda, and to better promote the health and well-being of the American people, the U.S. Department of Health and Human Services (HHS) is planning the largest deregulatory effort in the history of the Department.

The U.S. Department of Health and Human Services (HHS) released a statement announcing the complete reconstitution of the Advisory Committee for Immunization Practices (ACIP).